Guard Medical Reports An $11 Million Series B Investment For Its Novel Npsealtm, The First All-In-One Npwt Surgical Dressing

Privately-held company Guard Medical Inc. today announces the completion of a Series B investment of $11 million to support commercialization and clinical studies of its next generation Negative Pressure Wound Therapy (NPWT) dressing NPsealTM for the treatment of closed surgical incisions. NPsealTM is an easy-to-use and cost-effective NPWT surgical dressing with an integrated pump that establishes and maintains negative pressure with just a few pinches.